Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11834511 Compositions and methods for CD20 immunotherapy

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
November 24, 2020
0
Date of Patent
December 5, 2023
0
Patent Application Number
17103762
0
Patent Citations
‌
US Patent 8119772 MART-1 T cell receptors
0
‌
US Patent 8802374 Truncated epiderimal growth factor receptor (EGFRt) for transduced T cell selection
0
‌
US Patent 8679767 Multiple reaction monitoring LC-MS/MS method to detect therapeutic antibodies in animal samples using framework signature peptides
0
‌
US Patent 8822647 Method and compositions using a chimeric antigen receptor for enhanced anti-tumor effector functioning of T cells
0
‌
US Patent 7446191 DNA construct encoding CE7-specific chimeric T cell receptor
0
‌
US Patent 7514537 Chimeric immunoreceptor useful in treating human gliomas
0
Patent Inventor Names
Brian Till
0
Oliver Press
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11834511
0
Patent Primary Examiner
‌
Mark Halvorson
0
CPC Code
‌
A61K 2039/505
0
‌
A61K 2039/507
0
‌
C07K 14/7051
0
‌
C07K 2317/24
0
‌
C07K 2317/622
0
‌
C07K 2317/73
0
‌
A61K 39/39558
0
‌
A61K 38/00
0
‌
A61P 35/00
0

Find more entities like US Patent 11834511 Compositions and methods for CD20 immunotherapy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo